Parkinson's Disease Flashcards
Definition
Neurodegenerative disease of the dopaminergic neurones of the substantia nigra, characterised by:
o Bradykinesia
o Rigidity
o Resting tremor
o Postural instability
Pathophysiology
o Degeneration of dopaminergic neurones projecting from the substantia nigra to the striatum
o Patients are only symptomatic after the loss of > 70% of dopaminergic neurones
Aetiology
• Sporadic/Idiopathic Parkinson’s Disease
o Most COMMON
o Aetiology UNKNOWN
o May be related to environmental toxins and oxidative stress
• Secondary Parkinson’s Disease
o Neuroleptic therapy (e.g. for schizophrenia)
o Vascular insults (e.g. in the basal ganglia)
o MPTP toxin from illicit drug contamination
o Post-encephalitis
o Repeated head injury
• There are some familial forms of Parkinson’s disease
Epidemiology
- Very COMMON
- Prevalence: 1-2% of > 60 yrs
- Mean age of onset: 57 yrs
Presenting symptoms
- INSIDIOUS onset
- Resting tremor (mainly in hands)
- Stiffness and slowness of movements
- Difficulty initiating movements
- Frequent falls
- Smaller hand writing (micrographia)
- Insomnia
- Mental slowness (bradyphenia)
Signs on physical examination (tremor)
o Pill rolling rest tremor
o 4-6 Hz
o Decreased on action
o Usually asymmetrical
Signs on physical examination (rigidity)
o Lead pipe rigidity of muscle tone
o Superimposed tremor can cause cogwheel rigidity
o Rigidity can be enhanced by distraction
Signs on physical examination (gait)
o Stooped o Shuffling o Small-stepped gait o Reduced arm swing o Difficulty initiating walking
Signs on physical examination (postural instability)
o Falls easily with little pressure from the back or the front
Signs on physical examination (other features)
o Frontalis overactivation (leads to furrowing of the brow) o Hypomimic face o Soft monotonous voice o Impaired olfaction o Tendency to drool o Mild impairment of up-gaze
Signs on physical examination (psychiatric)
o Depression
o Cognitive problems and dementia (in later stages)
Investigations
• CLINICAL diagnosis
• Levodopa Trial
o Timed walking and clinical assessment after administration of levodopa
• Bloods
o Serum caeruloplasmin - rule out Wilson’s disease as a cause of Parkinson’s
disease
• CT or MRI Brain
o To exclude other causes of gait decline (e.g. hydrocephalus)
• Dopamine Transporter Scintigraphy
o Reduction in striatum and putamen